National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2017) Pehmeäkantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2019) Kovakantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2019) Pehmeäkantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2020) Pehmeäkantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2020) Pehmeäkantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2020) Pehmeäkantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2021) Pehmeäkantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2020) Pehmeäkantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2021) Pehmeäkantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2022) Pehmeäkantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2022) Pehmeäkantinen kirja
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public H National Academies Press (2023) Pehmeäkantinen kirja
Institute of Medicine; Board on Population Health and Public Health Practice; Committee on Public Health Strategies to Improve H National Academies Press (2011) Pehmeäkantinen kirja
Institute of Medicine; Board on Population Health and Public Health Practice; Committee on Public Health Strategies to Improve H National Academies Press (2011) Pehmeäkantinen kirja
Institute of Medicine; Board on Population Health and Public Health Practice; Committee on Integrating Primary Care and Public H National Academies Press (2012) Pehmeäkantinen kirja
Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk.
However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively.
Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agenda—outlining gaps in current knowledge and opportunities for providing additional insight into these issues—that summarizes and prioritizes pressing research needs.
Table of Contents
Front Matter Summary 1 Introduction 2 Cannabis 3 Cannabis: Prevalence of Use, Regulation, and Current Policy Landscape 4 Therapeutic Effects of Cannabis and Cannabinoids 5 Cancer 6 Cardiometabolic Risk 7 Respiratory Disease 8 Immunity 9 Injury and Death 10 Prenatal, Perinatal, and Neonatal Exposure to Cannabis 11 Psychosocial 12 Mental Health 13 Problem Cannabis Use 14 Cannabis Use and the Abuse of Other Substances 15 Challenges and Barriers in Conducting Cannabis Research 16 Recommendations to Support and Improve the Cannabis Research Agenda Appendix A Glossary Appendix B Study Approach Appendix C Systematic Reviews Appendix D Public Session Agendas Appendix E Biographical Sketches for Committee Members, Staff, Fellow, and Advisor